Pharma cos must focus on innovation: Biocon's Shaw
We haven't written up this one. The Economic Times has the full story — the link below goes straight to it.
More in Health & Medicine
STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences rare disease drug
Jerusalem court upholds 5-year suspension for gynecologist Guy Rofe over patient exploitation
“I will examine you as a gynecologist and as a lover,” he wrote to one patient, according to the judgment. She was a 19-year-old soldier whom he treated while serving as a military doctor.
- Jerusalem District Court upholds 5-year suspension of Guy Rofe's medical license
- Rofe engaged in improper behavior, mixing medical advice with intimate relationships
- Rofe continued advertising as practicing gynecologist despite suspended license
‘Drug use, mental illness feed each other’ – NDLEA boss Marwa
The Chairman and Chief Executive Officer of the National Drug Law Enforcement Agency (NDLEA), Brig. Gen. Mohamed Buba Marwa (retd), has said that drug use and mental illness feed each other, warning…
Celeb Accused of Assaulting Nurse; 24M New Dementia Cases; Inappropriate Prescribing
(MedPage Today) -- Note that some links may require registration or subscription. Actress Selma Blair, who has multiple sclerosis, was accused of kicking a nurse at a hospital following an alleged…
Pope Leo hospitalized ahead of surgery on lung nodule
Catholics are praying for Pope Leo XIV's health as he prepares for lung surgery. CBS News' Chris Livesay reports.
Exposure to 'safer' plastic additive during pregnancy linked to smaller birth size
A chemical used to make plastic more flexible, once introduced as a safer substitute for older additives now known to be harmful, may itself be harmful, slowing babies' growth in the womb, a new study…